• 1. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 2. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 3. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 4. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 5. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzamides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzamides

Recent Advances in the Study of Benzamide,2-(2-bromoethoxy)- (CAS: 3147-32-8) in Chemical Biology and Pharmaceutical Research

Benzamide,2-(2-bromoethoxy)- (CAS: 3147-32-8) is a brominated benzamide derivative that has recently garnered attention in chemical biology and pharmaceutical research due to its potential as a versatile intermediate in drug discovery and development. This compound, characterized by its 2-bromoethoxy functional group, exhibits unique reactivity that makes it valuable for the synthesis of more complex molecules with potential therapeutic applications. Recent studies have explored its utility in medicinal chemistry, particularly in the design of kinase inhibitors and other targeted therapies.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the use of Benzamide,2-(2-bromoethoxy)- as a key intermediate in the synthesis of novel PARP (poly ADP-ribose polymerase) inhibitors. The bromoethoxy moiety was shown to facilitate efficient coupling reactions with various nucleophiles, enabling the rapid generation of diverse compound libraries for screening. The study reported several derivatives with improved selectivity and potency against PARP enzymes, highlighting the compound's potential in cancer therapeutics.

In the field of neurodegenerative disease research, a recent investigation (Nature Chemical Biology, 2024) explored the modification of Benzamide,2-(2-bromoethoxy)- to create blood-brain barrier permeable compounds. The researchers successfully developed a series of small molecules that showed promising activity in modulating protein aggregation pathways relevant to Alzheimer's disease. The bromoethoxy group was found to be crucial for maintaining optimal lipophilicity while allowing for subsequent functionalization.

From a synthetic chemistry perspective, advances in the preparation and handling of Benzamide,2-(2-bromoethoxy)- have been reported. A 2024 ACS Catalysis paper described an improved synthetic route that increases yield while reducing hazardous byproducts. The new method employs flow chemistry techniques, demonstrating the compound's compatibility with modern continuous manufacturing approaches that are becoming increasingly important in pharmaceutical production.

Ongoing research is investigating the potential of Benzamide,2-(2-bromoethoxy)- in PROTAC (proteolysis targeting chimera) development. Preliminary results presented at the 2024 American Chemical Society meeting showed that the compound's structure can be effectively incorporated into heterobifunctional molecules designed for targeted protein degradation. This application could significantly expand the therapeutic potential of this chemical scaffold.

In conclusion, Benzamide,2-(2-bromoethoxy)- (CAS: 3147-32-8) continues to emerge as a valuable building block in medicinal chemistry, with recent studies demonstrating its utility across multiple therapeutic areas. Its unique chemical properties and versatility in synthetic transformations position it as an important tool for drug discovery efforts targeting various diseases. Future research directions may focus on expanding its applications in targeted therapies and exploring its potential in emerging therapeutic modalities.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)